144 related articles for article (PubMed ID: 23470797)
1. In-depth research of multidrug resistance related cell surface glycoproteome in gastric cancer.
Li K; Sun Z; Zheng J; Lu Y; Bian Y; Ye M; Wang X; Nie Y; Zou H; Fan D
J Proteomics; 2013 Apr; 82():130-40. PubMed ID: 23470797
[TBL] [Abstract][Full Text] [Related]
2. Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer.
Wu J; Qin H; Li T; Cheng K; Dong J; Tian M; Chai N; Guo H; Li J; You X; Dong M; Ye M; Nie Y; Zou H; Fan D
Oncotarget; 2016 May; 7(18):25315-27. PubMed ID: 27015365
[TBL] [Abstract][Full Text] [Related]
3. iTRAQ quantitative analysis of multidrug resistance mechanisms in human gastric cancer cells.
Hu HD; Ye F; Zhang DZ; Hu P; Ren H; Li SL
J Biomed Biotechnol; 2010; 2010():571343. PubMed ID: 20625496
[TBL] [Abstract][Full Text] [Related]
4. Probing the O-glycoproteome of gastric cancer cell lines for biomarker discovery.
Campos D; Freitas D; Gomes J; Magalhães A; Steentoft C; Gomes C; Vester-Christensen MB; Ferreira JA; Afonso LP; Santos LL; Pinto de Sousa J; Mandel U; Clausen H; Vakhrushev SY; Reis CA
Mol Cell Proteomics; 2015 Jun; 14(6):1616-29. PubMed ID: 25813380
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
6. Integrated proteomic and N-glycoproteomic analyses of doxorubicin sensitive and resistant ovarian cancer cells reveal glycoprotein alteration in protein abundance and glycosylation.
Ji Y; Wei S; Hou J; Zhang C; Xue P; Wang J; Chen X; Guo X; Yang F
Oncotarget; 2017 Feb; 8(8):13413-13427. PubMed ID: 28077793
[TBL] [Abstract][Full Text] [Related]
7. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.
Zhang X; Bo P; Liu L; Zhang X; Li J
Biomed Pharmacother; 2017 Aug; 92():580-585. PubMed ID: 28578256
[TBL] [Abstract][Full Text] [Related]
9. Silencing of ER-resident oxidoreductase PDIA3 inhibits malignant biological behaviors of multidrug-resistant gastric cancer.
Song D; Guo M; Wu K; Hao J; Nie Y; Fan D
Acta Biochim Biophys Sin (Shanghai); 2021 Aug; 53(9):1216-1226. PubMed ID: 34363072
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
11. β-Casein micelles for oral delivery of SN-38 and elacridar to overcome BCRP-mediated multidrug resistance in gastric cancer.
Bar-Zeev M; Kelmansky D; Assaraf YG; Livney YD
Eur J Pharm Biopharm; 2018 Dec; 133():240-249. PubMed ID: 30367935
[TBL] [Abstract][Full Text] [Related]
12. The Roles of microRNAs in Multidrug-Resistance Mechanisms in Gastric Cancer.
Zeng X; Wang HY; Bai SY; Pu K; Wang YP; Zhou YN
Curr Mol Med; 2020; 20(9):667-674. PubMed ID: 32209033
[TBL] [Abstract][Full Text] [Related]
13. Conditioned medium mimicking the tumor microenvironment augments chemotherapeutic resistance via ataxia‑telangiectasia mutated and nuclear factor‑κB pathways in gastric cancer cells.
Zhuang X; Li X; Zhang J; Hu Y; Hu B; Shi Y; Sun Y; Hong G
Oncol Rep; 2018 Oct; 40(4):2334-2342. PubMed ID: 30106453
[TBL] [Abstract][Full Text] [Related]
14. A peptide derived from phage display library exhibits anti-tumor activity by targeting GRP78 in gastric cancer multidrug resistance cells.
Kang J; Zhao G; Lin T; Tang S; Xu G; Hu S; Bi Q; Guo C; Sun L; Han S; Xu Q; Nie Y; Wang B; Liang S; Ding J; Wu K
Cancer Lett; 2013 Oct; 339(2):247-59. PubMed ID: 23792224
[TBL] [Abstract][Full Text] [Related]
15. Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells.
Zhao Y; You H; Liu F; An H; Shi Y; Yu Q; Fan D
Cancer Lett; 2002 Nov; 185(2):211-8. PubMed ID: 12169395
[TBL] [Abstract][Full Text] [Related]
16. Identification of proteins responsible for the development of adriamycin resistance in human gastric cancer cells using comparative proteomics analysis.
Yang YX; Hu HD; Zhang DZ; Ren H
J Biochem Mol Biol; 2007 Nov; 40(6):853-60. PubMed ID: 18047778
[TBL] [Abstract][Full Text] [Related]
17. Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation.
Wu J; Chen S; Liu H; Zhang Z; Ni Z; Chen J; Yang Z; Nie Y; Fan D
J Exp Clin Cancer Res; 2018 Nov; 37(1):272. PubMed ID: 30413206
[TBL] [Abstract][Full Text] [Related]
18. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA].
Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D
Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626
[TBL] [Abstract][Full Text] [Related]
19. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
[TBL] [Abstract][Full Text] [Related]
20. Efficient isolation and proteomic analysis of cell plasma membrane proteins in gastric cancer reveal a novel differentiation and progression related cell surface marker, R-cadherin.
Chen B; Luo QC; Chen JB; Lin LE; Luo MX; Ren HY; Chen PQ; Shi LG
Tumour Biol; 2016 Sep; 37(9):11775-11787. PubMed ID: 27029387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
